'Invisible' inflammation in rare bowel disease may explain heightened colon cancer risk

New research from the Garvan Institute of Medical Research has revealed for the first time that two closely related bowel diseases, currently treated in the same way, are fundamentally different. The findings help explain why one carries a much higher risk of colon cancer—and point to the need for different approaches to treatment.

Read it at Medical Xpress ↗

← Front page